Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Poplack

Showing results (211-220 of 227) with videos related to

Pageof 23
Sort By:
Cancer Research|September 1, 1981
Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemiaD G Poplack, S E Sallan, G Rivera, et al.
Cancer|March 1, 1978
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapseF R Appelbaum, A B Deisseroth, R G Graw, et al.
Cancer Research|August 1, 1990
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day scheduleP C Adamson, F M Balis, J Miser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trialS M Blaney, N L Seibel, M O'Brien, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1988
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndromeP Rogers, C J Allegra, R F Murphy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1987
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeysJ A Kelley, C L Litterst, J S Roth, et al.
Blood Advances|December 4, 2018
Capacity building: a novel pediatric hematology-oncology fellowship program in sub-Saharan AfricaJ Lubega, G Airewele, E Frugé, et al.
Cancer Research|March 15, 1989
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumorsJ A Moscow, C R Fairchild, M J Madden, et al.
Neuroendocrinology|January 1, 1985
Active clearance of corticotropin-releasing factor from the cerebrospinal fluidE H Oldfield, H M Schulte, G P Chrousos, et al.
Pageof 23

Showing results (211-220 of 227) with videos related to

Sort By:
Pageof 23
Cancer Research|September 1, 1981
Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemiaD G Poplack, S E Sallan, G Rivera, et al.
Cancer|March 1, 1978
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapseF R Appelbaum, A B Deisseroth, R G Graw, et al.
Cancer Research|August 1, 1990
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day scheduleP C Adamson, F M Balis, J Miser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trialS M Blaney, N L Seibel, M O'Brien, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1988
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndromeP Rogers, C J Allegra, R F Murphy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1987
The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeysJ A Kelley, C L Litterst, J S Roth, et al.
Blood Advances|December 4, 2018
Capacity building: a novel pediatric hematology-oncology fellowship program in sub-Saharan AfricaJ Lubega, G Airewele, E Frugé, et al.
Cancer Research|March 15, 1989
Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumorsJ A Moscow, C R Fairchild, M J Madden, et al.
Neuroendocrinology|January 1, 1985
Active clearance of corticotropin-releasing factor from the cerebrospinal fluidE H Oldfield, H M Schulte, G P Chrousos, et al.
Pageof 23